Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Faber

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Annals of the Royal College of Surgeons of England|March 25, 2009
Restoration and Rebuilding of the CollegeO Faber
Health Estate|January 6, 2001
New Worcester hospitalO Faber
Transactions of the St. John'S Hospital Dermatological Society|January 1, 1973
Penetration of protective gloves by allergens and irritantsH T Moursiden, O Faber
Diabetologia|September 1, 1978
Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirementC Eff, O Faber, T Deckert
Clinical Physiology (Oxford, England)|February 1, 1982
Effect of bicycle exercise on insulin absorption and subcutaneous blood flow in the normal subjectE Ferrannini, B Linde, O Faber
Acta Pharmacologica Et Toxicologica|August 1, 1974
The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjectsH T Mouridsen, O Faber, L Skovsted
Ugeskrift for Laeger|December 11, 1995
[Does Iodine 131 treatment of goiter result in an acute increase of the volume and function of the thyroid gland?]B Nygaard, J O Faber, L Hegedüs
Acta Pharmacologica Et Toxicologica|May 1, 1976
The pharmacokinetics of cyclophosphamide in man following treatment with methotrexateH T Mouridsen, E Jacobsen, O Faber
Cancer|February 1, 1976
The metabolism of cyclophosphamide. Dose dependency and the effect of long-term treatment with cyclophosphamideH T Mouridsen, O Faber, L Skovsted
Diabetes Care|March 1, 1984
Insulin pharmacokineticsC Binder, T Lauritzen, O Faber, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Annals of the Royal College of Surgeons of England|March 25, 2009
Restoration and Rebuilding of the CollegeO Faber
Health Estate|January 6, 2001
New Worcester hospitalO Faber
Transactions of the St. John'S Hospital Dermatological Society|January 1, 1973
Penetration of protective gloves by allergens and irritantsH T Moursiden, O Faber
Diabetologia|September 1, 1978
Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirementC Eff, O Faber, T Deckert
Clinical Physiology (Oxford, England)|February 1, 1982
Effect of bicycle exercise on insulin absorption and subcutaneous blood flow in the normal subjectE Ferrannini, B Linde, O Faber
Acta Pharmacologica Et Toxicologica|August 1, 1974
The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjectsH T Mouridsen, O Faber, L Skovsted
Ugeskrift for Laeger|December 11, 1995
[Does Iodine 131 treatment of goiter result in an acute increase of the volume and function of the thyroid gland?]B Nygaard, J O Faber, L Hegedüs
Acta Pharmacologica Et Toxicologica|May 1, 1976
The pharmacokinetics of cyclophosphamide in man following treatment with methotrexateH T Mouridsen, E Jacobsen, O Faber
Cancer|February 1, 1976
The metabolism of cyclophosphamide. Dose dependency and the effect of long-term treatment with cyclophosphamideH T Mouridsen, O Faber, L Skovsted
Diabetes Care|March 1, 1984
Insulin pharmacokineticsC Binder, T Lauritzen, O Faber, et al.
Pageof 3